Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer
Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer
Recruiting · NCT07094685 · Registry updated 2026-06-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer | Advanced Head and Neck Squamous Cell Carcinoma; Resectable Head and Neck Squamous Cell Carcinoma; Stage II Head and Neck Cutaneous Squamous Cell Carcinoma; Stage III Head and Neck Cutaneous Squamous Cell Carcinoma; Stage IV Head and Neck Cutaneous Squamous Cell Carcinoma | Recruiting | Phase 2 | 2026-06-26 | NCT07094685 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Summit Therapeutics | 31 |
| University of Michigan Rogel Cancer Center | 63 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Michigan Comprehensive Cancer Center | Ann Arbor | United States | 88 |